Startup Focus: Stemina Eyes Dx Future through Stem Cells-Metabolomics Approach

While using stem cells allows Stemina to "make the tissue type of interest. It's an all-human system," and allows the firm to build "the best potential in vitro environment to study a particular question," its CEO said.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.